Skip to content

Clinical evaluation of two step and ten method massage in the treatment of lumbar disc herniation

Clinical evaluation of two step and ten method massage in the treatment of lumbar disc herniation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004423
Enrollment
Unknown
Registered
2020-11-05
Start date
2021-03-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar disc herniation

Interventions

Sponsors

Affiliated Hospital of Changchun University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) It was in accordance with the diagnostic criteria of Western medicine; (2) According to the syndrome differentiation standard of TCM; (3) The age ranged from 18 to 60 years old, male or female; (4) Patients with 30% <= lumbar disability index (ODI) score <= 80%; (5) The patients whose waist and leg pain score <= 30mm <= 80mm; (6) No NSAIDs and other anti-inflammatory and analgesic drugs were used in the first week; (7) Informed consent and sign informed consent form.

Exclusion criteria

Exclusion criteria: (1) Pregnant or lactating women; (2) People with allergic constitution or allergic to this drug; (3) Recurrent lumbar disc herniation after operation; (4) Asymptomatic lumbar disc herniation, non discogenic low back pain; (5) Lumbar disc herniation complicated with cauda equina syndrome and conus medullaris syndrome; (6) Lumbar disc herniation combined with lumbar tumor or tuberculosis, lumbar spondylolisthesis above II 0, lumbar spinal stenosis, ankylosing spondylitis and severe osteoporosis; (7) Lumbar disc herniation with severe hypertension, heart disease and other organs or systems of serious primary diseases, mental patients; (8) Acute and chronic pain in other parts of the body, such as migraine, bone and joint pain, affects the patient's description of pain; (9) Those who have received epidural block, interventional therapy and operation recently; (10) Known allergy to Yaobitong capsule; (11) Patients with heart, liver and kidney (ALT, AST >= normal upper limit, Cr > normal upper limit), hematopoietic system, endocrine system and other serious primary diseases, psychosis, epilepsy; (12) Patients who have participated in other clinical trials within three months; (13) The researchers considered that it was not suitable for this study.

Design outcomes

Primary

MeasureTime frame
The Oswestry Disability Index;

Countries

China

Contacts

Public ContactLeng Xiangyang

Changchun University of Traditional Chinese Medicine

Lengxy@163.com+86 15948000708

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026